Core Laboratories Inc. reported a strong fourth quarter in 2025, with revenue reaching $138.3 million, a 7% increase year-over-year, surpassing guidance. Operating income stood at $15.8 million, and diluted EPS was $0.15. The company also reduced net debt by $1.2 million and repurchased 363,207 shares of common stock.
Fourth quarter revenue increased by 7% year-over-year to $138.3 million, exceeding guidance.
Operating income for the fourth quarter was $15.8 million, with ex-items operating income at $15.7 million.
Diluted GAAP EPS was $0.15, while ex-items EPS was $0.21.
The company generated $5.1 million in free cash flow and reduced net debt by $1.2 million, improving its leverage ratio to 1.09.
Core Lab projects first quarter 2026 revenue to be between $124 million and $130 million, with operating income ranging from $9.7 million to $12.2 million, and EPS between $0.11 and $0.15. This guidance reflects a higher interest rate due to a term loan and an effective tax rate of 25%.
Analyze how earnings announcements historically affect stock price performance